Clinical Trials · NCT07191873
Tirzepatide in Idiopathic Intracranial Hypertension Trial
- Phase
- Phase 4
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Duke University
- Enrollment
- 60
- Start date
- Feb 2026
- Locations
- 1 site, United States
- Primary endpoint
- Change in intracranial pressure in Idiopathic Intracranial Hypertension (IIH) patients